News
IDXG
2.840
+5.97%
0.160
Weekly Report: what happened at IDXG last week (1209-1213)?
Weekly Report · 5d ago
Weekly Report: what happened at IDXG last week (1202-1206)?
Weekly Report · 12/09 09:32
Weekly Report: what happened at IDXG last week (1125-1129)?
Weekly Report · 12/02 09:32
Weekly Report: what happened at IDXG last week (1118-1122)?
Weekly Report · 11/25 09:30
Weekly Report: what happened at IDXG last week (1111-1115)?
Weekly Report · 11/18 09:29
Weekly Report: what happened at IDXG last week (1104-1108)?
Weekly Report · 11/11 09:32
Based on the provided financial report articles, I generated the title for the article: "Consolidated Balance Sheets and Statements of Changes in Stockholders' Equity (Unaudited) for the Three and Nine Months Ended September 30, 2024, and the Year Ended December 31, 2023, and the Three and Nine Months Ended September 30, 2023, and the Year Ended December 31, 2022" Please note that this title is based on the provided data and may not be the actual title of the article.
Press release · 11/10 05:37
Interpace Biosciences Reports Impressive Q3 2024 Growth
TipRanks · 11/06 04:35
Interpace Biosciences GAAP EPS of $0.31, revenue of $12.3M
Seeking Alpha · 11/04 22:33
INTERPACE BIOSCIENCES ANNOUNCES RECORD THIRD QUARTER 2024 FINANCIAL AND BUSINESS RESULTS
Reuters · 11/04 21:30
INTERPACE BIOSCIENCES Q3 NET INCOME USD 1.28 MILLION
Reuters · 11/04 21:30
Weekly Report: what happened at IDXG last week (1028-1101)?
Weekly Report · 11/04 09:32
Weekly Report: what happened at IDXG last week (1021-1025)?
Weekly Report · 10/28 09:30
Weekly Report: what happened at IDXG last week (1014-1018)?
Weekly Report · 10/21 09:30
Interpace Diagnostics Strategic Stock Exchange for Nasdaq Uplisting
TipRanks · 10/15 21:00
INTERPACE BIOSCIENCES ANNOUNCES CAPITAL RESTRUCTURING OF ITS PREFERRED STOCK AS A FIRST STEP TOWARD SEEKING AN UPLISTING OF ITS COMMON STOCK TO NASDAQ
Reuters · 10/15 20:05
Weekly Report: what happened at IDXG last week (1007-1011)?
Weekly Report · 10/14 09:36
Weekly Report: what happened at IDXG last week (0930-1004)?
Weekly Report · 10/07 09:33
Weekly Report: what happened at IDXG last week (0923-0927)?
Weekly Report · 09/30 09:32
Weekly Report: what happened at IDXG last week (0916-0920)?
Weekly Report · 09/23 09:31
More
Webull provides a variety of real-time IDXG stock news. You can receive the latest news about Interpace Biosciences Inc through multiple platforms. This information may help you make smarter investment decisions.
About IDXG
Interpace Biosciences, Inc. provides personalized medicine and offers specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Its clinical services, through Interpace Diagnostics, provide clinically useful molecular diagnostic tests, bioinformatics and pathology services for evaluating the risk of cancer by leveraging the technology in personalized medicine for improved patient diagnosis and management. It has five commercialized molecular tests and one test in a clinical evaluation program: PancraGEN, PanDNA, ThyGeNEXT, ThyraMIR v2, RespriDX, and BarreGEN. PancraGEN is for the diagnosis and prognosis of pancreatic cancer from pancreatic cysts. PanDNA is a molecular only version of PancraGEN that provides physicians a snapshot of a limited number of factors. ThyGeNEXT is for the diagnosis of thyroid cancer from thyroid nodules. RespriDX differentiates lung cancer of primary versus metastatic origin.